LEPTOMENINGEAL NEOPLASM
Clinical trials for LEPTOMENINGEAL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL NEOPLASM trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Dose hope for devastating brain cancer spread
Disease control OngoingThis early-stage trial is testing a new way to give an immunotherapy drug called nivolumab to patients with melanoma or lung cancer that has spread to the membranes surrounding the brain and spinal cord. The goal is to see if giving the drug directly into the spinal fluid, along …
Matched conditions: LEPTOMENINGEAL NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo enters first human trial for Tough-to-Treat lung cancer
Disease control OngoingThis is an early-stage trial testing a combination of two oral drugs, sapanisertib and telaglenastat, for patients with advanced non-small cell lung cancer that has spread and progressed after standard treatments. The main goals are to find the safest dose of the drug combination…
Matched conditions: LEPTOMENINGEAL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC